Cart
sales@molnova.com
PGMI-004A
CAS No. 1313738-90-7
PGMI-004A( —— )
Catalog No. M23473 CAS No. 1313738-90-7
PGMI-004A is an effective inhibitor of phosphoglycerate mutase 1 (IC50: 13.1 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 312 | In Stock |
|
| 50MG | 1224 | In Stock |
|
| 100MG | 1971 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePGMI-004A
-
NoteResearch use only, not for human use.
-
Brief DescriptionPGMI-004A is an effective inhibitor of phosphoglycerate mutase 1 (IC50: 13.1 μM).
-
DescriptionPGMI-004A is an effective inhibitor of phosphoglycerate mutase 1 (IC50: 13.1 μM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPhospholipase
-
Recptorphosphoglycerate mutase 1?(PGAM1)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1313738-90-7
-
Formula Weight463.38
-
Molecular FormulaC21H12F3NO6S
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (269.76 mM)
-
SMILESC1=CC=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)O)S(=O)(=O)NC4=CC=C(C=C4)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hitosugi T, et al. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell. 2012 Nov 13;22(5):585-600.
molnova catalog
related products
-
Lp-PLA2-IN-1
Lp-PLA2 -IN-1 suppresses Lp-PLA2 activity processes for their preparation.
-
PF 5212372
PF 5212372 (PLA-950, ZPL-521, ZPL 5212372) is a potent, selective inhibitor of cPLA2 (cytosolic phospholipase A2α) with IC50 of 7 nM.
-
Bromoenol lactone
Bromoenol lactone ((6E)-Bromoenol lactone) is a selective calcium-dependent phospholipase A2?(iPLA2β) and serine protease inhibitor that attenuates nicotine-induced breast cancer cell proliferation and migrations.
